Key result
Elevated RBP4 levels linked to AMI development and progression, particularly alongside obesity-related risk factors.
Why the study?
The study was conducted to investigate the relationship between retinol binding protein 4 (RBP4), acute myocardial infarction (AMI), and obesity, focusing on chronic and vascular inflammation.
Are elevated retinol binding protein 4 (RBP4) levels associated with acute myocardial infarction risk in obese individuals?
Are elevated retinol binding protein 4 (RBP4) levels associated with acute myocardial infarction risk in obese individuals?
Answers are grounded in this paper and cite their sources.
Elevated RBP4 levels correlate with chronic and vascular inflammation and may serve as a potential biomarker for AMI risk assessment, particularly in obese individuals.
Acute myocardial infarction (AMI), a critical manifestation of ischemic heart disease, significantly contributes to global cardiovascular mortality. This study explores the role of retinol binding protein 4 (RBP4), which is linked to both obesity and AMI. Elevated levels of RBP4 are associated with an increased risk of these conditions. The objective is to investigate the relationship between RBP4, AMI, and obesity, focusing on chronic and vascular inflammation. To achieve this, multiple search strategies were employed, including electronic database searches of PubMed, Medline, EMBASE, Web of Science, and Google Scholar, using MeSH terms, keywords, and title words. This structured review process targeted studies on RBP4, AMI, and obesity to provide insights into how RBP4 levels impact AMI, especially in obese individuals. The findings suggest that elevated RBP4 levels are associated with the development and progression of AMI, particularly in the context of obesity-related risk factors. Elevated RBP4 levels, potentially influenced by decreased renal clearance as indicated in recent studies, correlate with mechanisms of chronic and vascular inflammation, highlighting its potential utility as a biomarker for AMI risk assessment, though further research is needed to elucidate causative pathways. Understanding the interaction between RBP4, obesity, and AMI could lead to more effective interventions to reduce cardiovascular disease globally.
No takes yet. Share an insight, caveat, or question.
Sunita et al. (2025) conducted a review in Acute myocardial infarction and obesity. Elevated retinol binding protein 4 (RBP4) levels was evaluated on Development and progression of acute myocardial infarction. Elevated retinol binding protein 4 (RBP4) levels are associated with the development and progression of acute myocardial infarction, particularly in the context of obesity-related risk factors.
Synapse has enriched 10 related papers. Consider them for comparative context: